- Filed
- Apr 29, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 21, 2025 | 39.73M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $935.2M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $763.57M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $22.18B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $21.93B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $23.6B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $23.42B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 39.63M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $3.32M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $28.06M |
| Capex | Q1 2025 · Mar 31, 2024 | $2.86M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $55.34M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.44B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.41B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.87 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.87 |
| Net Income | Q1 2025 · Mar 31, 2024 | $36.39M |